Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations.
Saved in:
| Title: | Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations. |
|---|---|
| Authors: | Li Y; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Yang Z; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Wu F; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Liang Q; Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Herman JG; UPMC Hillman Cancer Center, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Brock MV; Department of Surgery, The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Liu W; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Yu F; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., He X; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. hexuehuxi@csu.edu.cn.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. hexuehuxi@csu.edu.cn., Chen C; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. chenchen1981412@csu.edu.cn.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. chenchen1981412@csu.edu.cn. |
| Source: | Clinical epigenetics [Clin Epigenetics] 2025 Jun 02; Vol. 17 (1), pp. 90. Date of Electronic Publication: 2025 Jun 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Biomed Central Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
